Novavax awarded $1.6B federal grant toward production of coronavirus vaccine

Written by on 08/07/2020

Follow
( 0 Followers )
X

Follow

E-mail : *

Follow us on social media

TESTING AND MANUFACTURING OF THAT VACCINE. GAITHERSBURG BASED NOVAVAX THRUST INTO THE NATIONAL SPOTLIGHT, AFTER BEING CHOSEN TO PARTICIPATE IN THE WHITE HOUSE’S OPERATION WARP SPEED, A PROGRAM THAT AIMS TO BEGIN DELIVERING MILLIONS OF DOSES OF A SAFE, EFFECTIVE VACCINE FOR COVID-19 IN 2021.>> VALIDATES WHAT WE ARE DOING, THAT PEOPLE BELIEVE WE HAVE A GOOD VACCINE THAT NEEDS TO BE SUPPORTED AND BROUGHT TO THE PUBLIC. LOWELL: 11 NEWS SPOKE WITH NOVAVAC CHAIRMAN JIM YOUNG VIA ZOOM ABOUT THE ANNOUNCEMENT. THE MONEY, THE MOST GIVEN OUT BY THE WHITE HOUSE TO DATE, WILL HELP COMPLETE LATE-STAGE CLINICAL DEVELOPMENT, ESTABLISH LARGE-SCALE MANUFACTURING, AND DELIVER 100 MILLION DOSES OF A VACCINE POSSIBLY BY THE END OF THE YEAR. THE NOVAVAX GRANT GETTING THE ATTENTION OF GOVERNOR HOGAN, WHO TWEETED OUT A CONGRATULATIONS TO THE COMPANY, SAYING IN PART, “SINCE DAY ONE, I’VE SAID THAT MARYLAND’S BIOHEALTH INSTITUTIONS WOULD LEAD THE CHARGE TO DEVELOP TREATMENTS AND VACCINES.”>> WE ARE GRATEFUL TO THE COUNTY AND STATE FOR PROVIDING THE TYPE OF ENVIRONMENT THAT HELPS ADVANCE SCIENCE AND ADVANCE HEALTH FOR THE COMMUNITY. LOWELL: HUMAN TESTING OF THE VACCINE IS WELL UNDERWAY RIGHT NOW IN AUSTRALIA, WITH RESULTS EXPECTED BY THE END OF THE MONTH. THERE ARE A NUMBER OF OTHER COMPANIES WHO HAVE ALSO GOTTEN GRANTS FROM OPERATION WARP SPEED INCLUDING JOHNSON & JOHNSON AND MERCK, BUT YOUNG SAYS IT’S NOT A COMPETITION.>> EVERYBODY IS IN THIS TRYING TO GET ENOUGH VACCINE TO IMMUNIZE THE WORLD. WE ARE TRYING TO PRODUCE 6, 7 MILLION DOSES. NO ONE COMPANY CAN DO THAT. THERE IS PLENTY OF ROOM FOR EVERYBODY. LOWELL: WHILE THIS VACCINE IS EXPECTED TO COME OUT IN 2021, IF YOU WANT TO KEEP UP ON THE PROCESS AS TO WHERE NOVAVAX STANDS, WE HAVE LINK

Novavax awarded $1.6B federal grant toward production of coronavirus vaccine

A Maryland company scored a major victory in the race to find a COVID-19 vaccine.|| Coronavirus updates | Maryland’s latest numbers | Where to get tested ||Gaithersburg-based Novavax has been awarded a $1.6 billion federal grant to speed up the process for making a vaccine.Novavax has been working on a COVID-19 vaccine basically since the pandemic started. Novavax was thrust into the national spotlight after being chosen to participate in the White House’s Operation Warp Speed, a program that aims to begin delivering millions of doses of a safe, effective vaccine for COVID-19 in 2021.”(It) validates what we’re doing. People believe that we have a good vaccine and that needs to be supported and brought to the public,” Jim Young, chairman of Novavax, told 11 News Tuesday via Zoom.”We’re pretty confident this will stimulate a potent neutralizing immune response in humans,” Novavax president and CEO Stanley C. Erck said in a CNBC appearance Tuesday morning.Erck said the money — the most given out by the White House to date — will help complete late-stage clinical development, including a pivotal phase three clinical trial, establish large-scale manufacturing and deliver 100 million doses of a vaccine, possibly, by the end of the year.”To show that the vaccine is, No. 1, safe, that it’s effective and, if the vaccine is stable and in parallel, these things are usually done in sequence parallel, will be able to manufacture large quantities at multiple locations in five or six countries,” Erck said.The Novavax grant got the attention of Maryland Gov. Larry Hogan, who tweeted a congratulatory note to the company, saying, in part, “Since day one, I’ve said that Maryland’s biohealth institutions would lead the charge to develop treatments and vaccines.””We’re grateful to the county and the state for providing this type of environment that helps advance science and advance health for the community,” Young said.Human testing of the vaccine is well underway in Australia with results expected by the end of the month.There are a number of other companies that have also received Operation Warp Speed grants, including Johnson & Johnson and Merck, as the race continues toward a COVID-19 vaccine. But Young said it’s not a competition.”Everybody’s in this trying to get enough vaccine to immunize the world. We’re trying to produce 6 billion, 7 billion doses. No one company can do that. There’s plenty of room for everybody,” Young said.The vaccine is expected to come out sometime in 2021.MORE: Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May

GAITHERSBURG, Md. —

A Maryland company scored a major victory in the race to find a COVID-19 vaccine.

|| Coronavirus updates | Maryland’s latest numbers | Where to get tested ||

Gaithersburg-based Novavax has been awarded a $1.6 billion federal grant to speed up the process for making a vaccine.

Novavax has been working on a COVID-19 vaccine basically since the pandemic started. Novavax was thrust into the national spotlight after being chosen to participate in the White House’s Operation Warp Speed, a program that aims to begin delivering millions of doses of a safe, effective vaccine for COVID-19 in 2021.

“(It) validates what we’re doing. People believe that we have a good vaccine and that needs to be supported and brought to the public,” Jim Young, chairman of Novavax, told 11 News Tuesday via Zoom.

“We’re pretty confident this will stimulate a potent neutralizing immune response in humans,” Novavax president and CEO Stanley C. Erck said in a CNBC appearance Tuesday morning.

Erck said the money — the most given out by the White House to date — will help complete late-stage clinical development, including a pivotal phase three clinical trial, establish large-scale manufacturing and deliver 100 million doses of a vaccine, possibly, by the end of the year.

“To show that the vaccine is, No. 1, safe, that it’s effective and, if the vaccine is stable and in parallel, these things are usually done in sequence parallel, will be able to manufacture large quantities at multiple locations in five or six countries,” Erck said.

The Novavax grant got the attention of Maryland Gov. Larry Hogan, who tweeted a congratulatory note to the company, saying, in part, “Since day one, I’ve said that Maryland’s biohealth institutions would lead the charge to develop treatments and vaccines.”

I want to congratulate @Novavax of Gaithersburg for receiving the largest Operation Warp Speed grant yet to accelerate development of a #COVID19 vaccine. Since day one, I’ve said that Maryland’s biohealth institutions would lead the charge to develop treatments and vaccines. https://t.co/ZdqRxwEJnD

— Governor Larry Hogan (@GovLarryHogan) July 7, 2020

“We’re grateful to the county and the state for providing this type of environment that helps advance science and advance health for the community,” Young said.

Human testing of the vaccine is well underway in Australia with results expected by the end of the month.

There are a number of other companies that have also received Operation Warp Speed grants, including Johnson & Johnson and Merck, as the race continues toward a COVID-19 vaccine. But Young said it’s not a competition.

“Everybody’s in this trying to get enough vaccine to immunize the world. We’re trying to produce 6 billion, 7 billion doses. No one company can do that. There’s plenty of room for everybody,” Young said.

The vaccine is expected to come out sometime in 2021.

MORE: Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May

Read More

Tagged as

Current track

Title

Artist

Background
Do NOT follow this link or you will be banned from the site!